Privacyvoorkeur

MEDtalks houdt u graag op de hoogte van de laatste ontwikkelingen op uw interessegebied. Kies hieronder of u op de hoogte gehouden wilt blijven van de nieuwste programma's en nascholingen binnen uw interessegebieden. Klik hier voor meer informatie.


EHA 2020: Journaal NHL

Bekijk hier het MEDtalks EHA-journaal over non-Hodgkin lymfomen. In dit journaal bespreekt dr. Marcel Nijland zijn highlights van EHA 2020.

Het nieuws wordt besproken aan de hand van onderstaande EHA-abstracts:

  1. ROLE OF RADIOTHERAPY AND DOSE-DENSIFICATION OF R-CHOP IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A SUBGROUP ANALYSIS OF THE UNFOLDER TRIAL OF THE GERMAN LYMPHOMA ALLIANCE (GLA)
  2. HIGH DOSE METHOTREXATE CNS PROPHYLAXIS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A MULTICENTRE ANALYSIS OF TOXICITY AND IMPACT ON R-CHOP DELIVERY
  3. RE-MIND STUDY: COMPARISON OF TAFASITAMAB + LENALIDOMIDE (L-MIND) VS LENALIDOMIDE MONOTHERAPY (REAL-WORLD DATA) IN TRANSPLANT-INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
  4. EFFICACY AND SAFETY OF ATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMAS: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA
  5. CD20-TCB IN RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA: DURABLE COMPLETE RESPONSES AND MANAGEABLE SAFETY OBSERVED AT CLINICALLY RELEVANT DOSES IN PHASE I DOSE ESCALATION
  6. INOTUZUMAB OZOGAMICIN PLUS R-CVP IS A FEASIBLE AND EFFECTIVE REGIMEN FOR FRONTLINE TREATMENT OF DLBCL IN PATIENTS WHO ARE UNFIT FOR R-CHOP: RESULTS OF A RANDOMISED PHASE 2 UK NCRI TRIAL
  7. INITIAL RESULTS OF A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE, A NOVEL PYRROLOBENZODIAZEPINE-BASED ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
  8. OUTCOME OF LIMITED STAGE PERIPHERAL T-CELL LYMPHOMA AFTER CHOP(-LIKE) THERAPY: A POPULATION BASED STUDY OF 251 PATIENTS FROM THE NORDIC LYMPHOMA EPIDEMIOLOGY GROUP
  • Sponsoren

    Dit programma komt onafhankelijk tot stand en wordt financieel mogelijk gemaakt door

Gerelateerde publicaties